This topic contains a solution. Click here to go to the answer

Author Question: An antiemetic that potentiates the depressant effects on the CNS of narcotics, sedatives or ... (Read 67 times)

ETearle

  • Hero Member
  • *****
  • Posts: 580
An antiemetic that potentiates the depressant effects on the CNS of narcotics, sedatives or hypnotics, and alcohol and no longer used commonly by emergency medical services is:
 
  a. Ondansetron (Zofran)
  b. Dolasetron (Anzemet)
  c. Promethazine (Phenergan)
  d. Prochlorperazine (Compazine)

Question 2

A person with type A blood cannot receive type O blood.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

softEldritch

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

c
Rationale: a. Zofran is a serotonin antagonist having less effect on CNS depressants.
b. Dolastron is a serotonin antagonist having less effect on CNS depression.
c. Correct.
d. Prochlorperazine has weak anticholinergic properties having less effect on CNS depression.

Answer to Question 2

FALSE





 

Did you know?

Not getting enough sleep can greatly weaken the immune system. Lack of sleep makes you more likely to catch a cold, or more difficult to fight off an infection.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

The first-known contraceptive was crocodile dung, used in Egypt in 2000 BC. Condoms were also reportedly used, made of animal bladders or intestines.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library